Our goal is to transform healthcare one investment at a time.
By supporting diverse entrepreneurs who create and build breakthrough companies and treatments.
Discover our Portfolio
We empower innovators to improve patients’ lives.
And we have the track record to prove it.
- $4.0Bin historical commitments
Global private equity and venture capital investment platform. Specialized and diversified healthcare funds spanning all sectors and stages. Three teams focused on biotechnology (inc dementia), healthcare growth equity and medtech.
View our Strategies
- 75IPOs/M&As
Backing inspiring and talented innovators with diverse experiences to create healthcare industry leaders that attract strategic acquirers and public investors. Our portfolio companies’ remarkable work benefits patients while growing shareholder value for investors.
View our Portfolio
- 30yrtrack record in US and UK
One of the longest-tenured healthcare investment managers in the world. Experienced team of >50 investment professionals and operating partners based in Boston and London, adding value and guiding strategic direction.
Meet our People
Our People
SV is driven by our talented team and network. We bring together our experienced investment professionals with healthcare industry veterans to build value in breakthrough life sciences companies.
Meet our People
The latest from SV
We're proud to share our achievements and those of our portfolio companies.
AviadoBio Presents New Preclinical Data Validating the vMiX™ Platform for AVB-406 in Alzheimer’s Disease and for AVB-SNCA in Parkinson’s Disease at ESGCT 2026
Prilenia and Ferrer Announce Authorization for EU Initiation of Confirmatory PRECISE-HD Study of Pridopidine in Huntington's Disease
Promising Early Safety Data as Quell Therapeutics Advances QEL-005 – a Novel Engineered nTreg Therapy – to Second Dose Cohort in CHILL Phase 1/2 Trial in Difficult-to-Treat Rheumatoid Arthritis and Systemic Sclerosis
